Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Reshef

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Blood|October 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Blood Advances|February 15, 2018
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R McCurdy, Mei-Jie Zhang, Andrew St Martin, et al.
Blood|April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemiaEric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Blood Advances|April 16, 2024
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocolSarah Nikiforow, Jennifer S Whangbo, Ran Reshef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2021
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell TransplantationNeema P Mayor, Tao Wang, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2018
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention TrialsMarcelo C Pasquini, Brent Logan, Richard J Jones, et al.
Bone Marrow Transplantation|December 19, 2023
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository studyPhilip L McCarthy, Kristopher M Attwood, Xiaojun Liu, et al.
American Journal of Hematology|February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftmentElizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Blood|October 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Blood Advances|February 15, 2018
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R McCurdy, Mei-Jie Zhang, Andrew St Martin, et al.
Blood|April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemiaEric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Blood Advances|April 16, 2024
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocolSarah Nikiforow, Jennifer S Whangbo, Ran Reshef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2021
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell TransplantationNeema P Mayor, Tao Wang, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2018
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention TrialsMarcelo C Pasquini, Brent Logan, Richard J Jones, et al.
Bone Marrow Transplantation|December 19, 2023
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository studyPhilip L McCarthy, Kristopher M Attwood, Xiaojun Liu, et al.
American Journal of Hematology|February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftmentElizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Pageof 15